Next Milestone Ventures

Calder Biosciences is a vaccine immunogen design company that is developing novel RSV and universal Influenza subunit vaccines, both representing $ multi-billion market opportunities with mitigated clinical risk.

Team:

Christopher Marshall, Ph.D., Chief Executive Officer

Mark Yonda, Ph. D., Director of Research